Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
International Ophthalmology
Published in: International Ophthalmology 4/2020

01-04-2020 | Diabetic Retinopathy | Original Paper

Hydrogen sulfide serves as a biomarker in the anterior segment of patients with diabetic retinopathy

Authors: Yuyi Han, Xiaoqian Zhang, Zhiyin Zhou, Mengxi Yu, Qiuhong Wang, Jin Yao, Yi Han

Published in: International Ophthalmology | Issue 4/2020

Login to get access

Abstract

Objective

The present study aims to determine hydrogen sulfide (H2S) concentrations of the aqueous humor from patients with diabetic retinopathy (DR) to compare its levels in the anterior segments, also to investigate its effect on the retinal microvascular endothelial cells under high glucose condition.

Methods

AH samples were collected from patients with proliferative diabetic retinopathy (n = 11), non-proliferative diabetic retinopathy (n = 12) and diabetic patients without DR as controls (n = 12). There were 5 patients with PDR received intraocular anti-VEGF injection (Lucentis). Cultured RF/6A cells were grouped into control group, mannitol group, high glucose group and NaHS co-administrated high glucose group. Concentrations of H2S were detected by chemical assay. Cell apoptosis was evaluated by flow cytometry.

Results

A significantly higher H2S level was observed in AH samples of PDR patients among other groups. The H2S level of DR group was higher than that of control group. Decreased H2S levels in the AH of post-injected PDR patients were observed compared with their AH samples before the anti-VEGF injection. In cell culture, low concentration of NaHS can reverse high-glucose-induced apoptosis of RF/6A cells.

Conclusion

Our study revealed increased H2S levels in the anterior segments of different DR patients. The anti-VEGF injection reduced the H2S level in AH from PDR patients. The study suggested that H2S may serve as a biomarker in the progression of PDR. On the other hand, the H2S donor exerted a protective effect on retinal vascular endothelial cells against high-glucose-induced apoptosis.
Literature
1.
Simó R, Hernández C (2015) Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence. Prog Retinal Eye Res 48:160–180
2.
Nolan CJ, Damm P, Prentki M (2011) Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 378(9786):169–181PubMed
3.
Congdon NG, Friedman DS, Thomas L (2003) Important causes of visual impairment in the world today. JAMA 290(15):2057PubMed
4.
Whiting DR, Leonor G, Clara W, Jonathan S (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94(3):311–321PubMed
5.
Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35(3):556–564PubMedPubMedCentral
6.
Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, Klein R (2004) Retinopathy in diabetes. Diabetes Care 27(1):S84PubMed
7.
Akiko G, Masaru I, Toshihiro I, Nanako AK, Yuji T, Yasuhiro I, Mikiko F, Hidenobu T (2013) Frequency and risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy. J Glaucoma 22(7):572–576
8.
Hasnan J, Yusof MI, Damitri TD, Faridah AR, Adenan AS, Norbaini TH (2010) Relationship between apoptotic markers (Bax and Bcl-2) and biochemical markers in type 2 diabetes mellitus. Singap Med J 51(1):50–55
9.
Lu M, Adamis AP (2002) Vascular endothelial growth factor gene regulation and action in diabetic retinopathy. Ophthalmol Clin N Am 15(1):69–79
10.
Liu L, Xu Y, Huang Z, Wang X (2016) Intravitreal ranibizumab injection combined trabeculectomy versus Ahmed valve surgery in the treatment of neovascular glaucoma: assessment of efficacy and complications. BMC Ophthalmol 16(1):65PubMedPubMedCentral
11.
Adamis AP, Shima DT, Tolentino MJ, Gragoudas ES, Ferrara N, Folkman J, D'Amore PA, Miller JW (1996) Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol 114(1):66–71PubMed
12.
Gologorsky D, Thanos A, Vavvas D (2012) Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy. Med Inflam 10:629452
13.
Kulkarni M, Njie-Mbye YF, Okpobiri I, Zhao M, Opere CA, Ohia SE (2011) Endogenous production of hydrogen sulfide in isolated bovine eye. Neurochem Res 36(8):1540–1545PubMed
14.
Szabo C (2018) A timeline of hydrogen sulfide (H2S) research: from environmental toxin to biological mediator. Biochem Pharmacol 149:5–19PubMed
15.
Zanardo RCO, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL (2006) Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 20(12):2118–2120PubMed
16.
Kimura Y, Goto Y, Kimura H (2010) Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antiox Redox Signal 12(1):1
17.
Yan SK, Chang T, Hui W, Wu L, Rui W, Meng QH (2006) Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cells. Biochem Biophys Res Commun 351(2):485–491PubMed
18.
Mustafa AK, Gadalla MM, Sen N, Kim S, Mu W, Gazi SK, Barrow RK, Yang G, Wang R, Snyder SH (2009) H2S signals through protein S-sulfhydration. Sci Signal 2(96):ra72PubMedPubMedCentral
19.
Ran R, Du L, Zhang X, Chen X, Fang Y, Li Y, Tian H (2014) Elevated hydrogen sulfide levels in vitreous body and plasma in patients with proliferative diabetic retinopathy. Retina 34(10):2003–2009PubMed
20.
Papapetropoulos A, Pyriochou A, Altaany Z, Yang G, Marazioti A, Zhou Z, Jeschke MG, Branski LK, Herndon DN, Wang R (2009) Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci USA 106(51):21972PubMed
21.
Liu Z, Han Y, Li L, Lu H, Meng G, Li X, Shirhan M, Peh MT, Xie L, Zhou S (2013) The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E−/− mice. Br J Pharmacol 169(8):1795–1809PubMedPubMedCentral
22.
Li J, Wang P, Yu S, Zheng Z, Xu X (2012) Calcium entry mediates hyperglycemia-induced apoptosis through Ca(2+)/calmodulin-dependent kinase II in retinal capillary endothelial cells. Mol Vis 18(250):2371PubMedPubMedCentral
23.
Persa C, Osmotherly K, Chen CW, Moon S, Louabcd MF (2006) The distribution of cystathionine β-synthase (CBS) in the eye: Implication of the presence of a trans-sulfuration pathway for oxidative stress defense. Exp Eye Res 83(4):817–823PubMed
24.
Winnie WP, Renata S, Nina F, Jan PK, William DE (2010) Comparative localization of cystathionine beta-synthase and cystathionine gamma-lyase in retina: differences between amphibians and mammals. J Comp Neurol 505(2):158–165
25.
Lo Faro ML, Fox B, Whatmore JL, Winyard PG, Whiteman M (2014) Hydrogen sulfide and nitric oxide interactions in inflammation. Nitric Oxide Biol Chem 41(11):38
26.
Kimura H (2014) The physiological role of hydrogen sulfide and beyond. Nitric Oxide 41:4–10PubMed
27.
Qaum T, Xu Q, Joussen AM, Clemens MW, Qin W, Miyamoto K, Hassessian H, Wiegand SJ, Rudge J, Yancopoulos GD (2001) VEGF-initiated blood-retinal barrier breakdown in early diabetes. Investig Ophthalmol Visual Sci 42(10):2408
28.
Gersztenkorn D, Coletta C, Zhu S, Ha Y, Liu H, Tie H, Zhou J, Szabo C, Zhang W, Motamedi M (2016) Hydrogen sulfide contributes to retinal neovascularization in ischemia-induced retinopathy. Invest Ophthalmol Vis Sci 57(7):3002–3009PubMedPubMedCentral
29.
Liu Y, Zou LP, Du JB, Wong V (2010) Electro-acupuncture protects against hypoxic-ischemic brain-damaged immature rat via hydrogen sulfide as a possible mediator. Neurosci Lett 485(1):74–78PubMed
30.
Qingbo G, Wen L, Yuantao L, Youfei F, Xiaolei W, Chunxiao Y, Yuan Z, Shunke W, Jia L, Jiajun Z (2015) High glucose induces the release of endothelin-1 through the inhibition of hydrogen sulfide production in HUVECs. Int J Mol Med 35(3):810
31.
Monica RF, Virgil A, Kerrison JB, Jablon EP (2009) Ranibizumab for diabetic retinopathy. Curr Diabetes Rev 5(1):47–51
32.
Ning D, Bing X, Bingsong W, Liqun C (2013) Study of 27 aqueous humor cytokines in patients with type 2 diabetes with or without retinopathy. Mol Vis 19(1623):1734–1746
33.
Miller JW, Couter JL, Strauss EC, Ferrara N (2013) Vascular endothelial growth factor a in intraocular vascular disease. Ophthalmology 120(1):106–114PubMed
34.
Yanrong J, Xiaoying L, Xiaoxin L, Yong T, Kai W (2010) Analysis of the clinical efficacy of intravitreal bevacizumab in the treatment of iris neovascularization caused by proliferative diabetic retinopathy. Acta Ophthalmol 87(7):736–740
35.
Ababneh OH, Yousef YA, Gharaibeh AM, Ameerh MA, Abu A-Y, Bdour MD (2013) Intravitreal bevacizumab in the treatment of diabetic ocular neovascularization. Retina 33(4):748–755PubMed
36.
Ip MS, Amitha D, Jill JH, Pamela W, Ehrlich JS (2012) Long-term effects of ranibizumab on diabetic retinopathy severity and progression. Arch Ophthalmol 130(9):1145PubMed
37.
Gemici B, Elsheikh W, Feitosa KB, Costa SKP, Muscara MN, Wallace JL (2015) H2S-releasing drugs: anti-inflammatory, cytoprotective and chemopreventative potential. Nitric Oxide 46:25–31PubMed
38.
Wang MJ, Cai WJ, Li N, Ding YJ, Chen Y, Zhu YC (2010) The hydrogen sulfide donor NaHS promotes angiogenesis in a rat model of hind limb ischemia. Antiox Redox Signal 12(9):1065–1077
39.
Mccarty MF (1998) Nitric oxide deficiency, leukocyte activation, and resultant ischemia are crucial to the pathogenesis of diabetic retinopathy/ neuropathy—preventive potential of antioxidants, essential fatty acids, chromium, ginkgolides, and pentoxifylline. Med Hypotheses 50(50):435–449PubMed
40.
Kern TS, Yunpeng D, Miller CM, Hatala DA, Levin LA (2010) Overexpression of Bcl-2 in vascular endothelium inhibits the microvascular lesions of diabetic retinopathy. Am J Pathol 176(5):2550–2558PubMedPubMedCentral
41.
Liu Y-Y, Nagpure BV, Wong PTH, Bian J-S (2013) Hydrogen sulfide protects SH-SY5Y neuronal cells against d-galactose induced cell injury by suppression of advanced glycation end products formation and oxidative stress. Neurochem Int 62(5):603–609PubMed
42.
Oh GS, Pae HO, Lee BS, Kim BN, Kim JM, Kim HR, Jeon SB, Jeon WK, Chae HJ, Chung HT (2006) Hydrogen sulfide inhibits nitric oxide production and nuclear factor-κB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Rad Biol Med 41(1):106–119PubMed
43.
Bir SC, Kolluru GK, Mccarthy P, Shen X, Pardue S, Pattillo CB, Kevil CG (2012) Hydrogen sulfide stimulates ischemic vascular remodeling through nitric oxide synthase and nitrite reduction activity regulating hypoxia-inducible factor-1α and vascular endothelial growth factor-dependent angiogenesis. J Am Heart Assoc 1(5):e004093PubMedPubMedCentral
44.
Liu X (2010) Hypoxia-inducible factor-1α is involved in the pro-angiogenic effect of hydrogen sulfide under hypoxic stress. Biol Pharm Bull 33(9):1550–1554PubMed
Metadata
Title
Hydrogen sulfide serves as a biomarker in the anterior segment of patients with diabetic retinopathy
Authors
Yuyi Han
Xiaoqian Zhang
Zhiyin Zhou
Mengxi Yu
Qiuhong Wang
Jin Yao
Yi Han
Publication date
01-04-2020
Publisher
Springer Netherlands
Published in
International Ophthalmology / Issue 4/2020
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-019-01252-z

Other articles of this Issue 4/2020

International Ophthalmology 4/2020 Go to the issue

Original Paper

Characteristics of ‘sawtooth shunt’ following anti-vascular endothelial growth factor for aggressive posterior retinopathy of prematurity

Original Paper

EDI-OCT choroidal thickness in Posner–Schlossman syndrome

Original Paper

Corneal biomechanics in different age groups

Original Paper

Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study

Original Paper

Association between CFH single nucleotide polymorphisms and response to photodynamic therapy in patients with central serous chorioretinopathy

Original Paper

Link of ocular pseudoexfoliation syndrome and vascular system changes: results from 10-year follow-up study